MDT

82.5

-0.08%↓

VEEV

215.64

-2.19%↓

102.36

-0.28%↓

WBA

10.88

+0.65%↑

CHE

579.57

-0.25%↓

MDT

82.5

-0.08%↓

VEEV

215.64

-2.19%↓

102.36

-0.28%↓

WBA

10.88

+0.65%↑

CHE

579.57

-0.25%↓

MDT

82.5

-0.08%↓

VEEV

215.64

-2.19%↓

102.36

-0.28%↓

WBA

10.88

+0.65%↑

CHE

579.57

-0.25%↓

MDT

82.5

-0.08%↓

VEEV

215.64

-2.19%↓

102.36

-0.28%↓

WBA

10.88

+0.65%↑

CHE

579.57

-0.25%↓

MDT

82.5

-0.08%↓

VEEV

215.64

-2.19%↓

102.36

-0.28%↓

WBA

10.88

+0.65%↑

CHE

579.57

-0.25%↓

Kodu・Aktsiate loetelu・Imunon Inc

Imunon Inc

Suletud

0.85

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.8

Max

0.86

Põhinäitajad
By Trading Economics
Töötajad	25

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+1473.03% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	12. mai 2025

Turustatistika
By TradingEconomics
Turukapital	-1.1M 11M
Eelmine avamishind	0.85
Eelmine sulgemishind	0.85

Imunon Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

18. apr 2025, 15:57 UTC

Suurimad hinnamuutused turgudel

Eli Lilly CEO Ricks Warns Against Unintentionally Raising Prices as Weight-Loss Pill Nears Market Launch

18. apr 2025, 20:42 UTC

Omandamised, ülevõtmised, äriostud

What Bill Ackman Sees in Hertz and Why He's Betting Big on the Rental-Car Company -- Barrons.com

18. apr 2025, 20:32 UTC

Peamised uudised

Trump to Replace Acting IRS Commissioner -- 2nd Update

18. apr 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

18. apr 2025, 19:52 UTC

Market Talk

Correction to Aluminum Fee Rising Slower Than Forecast Article

18. apr 2025, 19:40 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

18. apr 2025, 19:40 UTC

Market Talk

Aluminum Fee Rising Slower Than Forecast From Tariff -- Market Talk

18. apr 2025, 18:51 UTC

Tulu

Netflix Has Made Several Risky Bets. Earnings Show They've Paid Off. -- Barrons.com

18. apr 2025, 18:40 UTC

Omandamised, ülevõtmised, äriostud

What Bill Ackman Sees in Hertz and Why He's Betting Big on the Rental-Car Company -- Barrons.com

18. apr 2025, 18:29 UTC

Market Talk

Shorter Duration Seen as Way to Shield Portfolio From Political Turbulence -- Market Talk

18. apr 2025, 18:21 UTC

Peamised uudised

Ford Halts Shipments of F-150s and Other Models to China -- WSJ

18. apr 2025, 17:31 UTC

Peamised uudised

Trump to Replace Acting IRS Commissioner -- WSJ

18. apr 2025, 17:24 UTC

Omandamised, ülevõtmised, äriostud

Capital One's Discover Takeover Gets the Green Light. The Two Will Create the 6th-Largest U.S. Bank. -- Barrons.com

18. apr 2025, 17:22 UTC

Omandamised, ülevõtmised, äriostud

Capital One's $35 Billion Discover Takeover Clears Final Approvals -- Barrons.com

18. apr 2025, 16:00 UTC

Peamised uudised

Trump's Trade War Threatens One of America's Top Energy Exports -- WSJ

18. apr 2025, 15:53 UTC

Peamised uudised

Omandamised, ülevõtmised, äriostud

Bill Ackman Teases Prospect of Uber, Hertz Partnership -- Update

18. apr 2025, 15:46 UTC

Tulu

Tech's Problems in China Are Getting Worse. These Companies Are Most at Risk. -- Barrons.com

18. apr 2025, 15:10 UTC

Market Talk

Tulu

Netflix Momentum Likely To Continue Thanks To Growing Subscriber Base -- Market Talk

18. apr 2025, 14:46 UTC

Tulu

Tech Earnings Have Good News for Chip Stocks, So Far. And 1 Warning. -- Barrons.com

18. apr 2025, 14:24 UTC

Market Talk

Tulu

Netflix Still Has Room to Add Subscribers -- Market Talk

18. apr 2025, 14:17 UTC

Tulu

Apple Is an Efficiency Champion. This Company Is Closing in on Its Crown. -- Barrons.com

18. apr 2025, 13:55 UTC

Peamised uudised

EU Delayed Punishing Apple, Meta Just Before Trade Talks Started -- WSJ

18. apr 2025, 11:21 UTC

Tulu

Netflix Stock Jumps on Earnings Beat. Why Tariffs Won't Hurt the Streamer. -- Barrons.com

18. apr 2025, 11:00 UTC

Peamised uudised

Amazon's Vast Empire Gives It a Leg Up in the Trade War -- Heard on the Street -- WSJ

18. apr 2025, 11:00 UTC

Peamised uudised

Johnson & Johnson Pivots Its AI Strategy -- WSJ

18. apr 2025, 10:36 UTC

Peamised uudised

Trump Signals China's Xi Has Reached Out About a Trade Deal. Here's the Latest on Tariffs. -- Barrons.com

18. apr 2025, 10:26 UTC

Peamised uudised

Why World Leaders Are Pulling Their Punches in the Trade War -- Update

18. apr 2025, 09:30 UTC

Peamised uudised

Now Streaming on Netflix: A Show Where Profits Trump the Trade War -- Heard on the Street -- Update

18. apr 2025, 08:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

18. apr 2025, 06:52 UTC

Market Talk

Nikkei Rises 1.0%, Led by Pharma, Shipping Stocks -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Imunon Inc Prognoos

Hinnasiht

By TipRanks

1473.03% tõus

12 kuu keskmine prognoos

Keskmine 14 USD 1473.03%

Kõrge 14 USD

Madal 14 USD

Põhineb 1 Wall Streeti analüütiku instrumendi Imunon Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi Imunon Inc aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Ettevõttest Imunon Inc

Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.